logo

PBM

Psyence Biomedical·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
6.86 / 10Overall Score
OutperformInvestment Rating
FundamentalSentimentTechnical
Is PBM a Good Buy Right Now?
  • Based on a composite score of 6.86/10, we rate PBM as a Outperform. Our analysis breaks down into 8.96/10 for Fundamentals, 3.95/10 for Technicals, and 7.66/10 for Sentiment, indicating the stock is likely to See further upside.
Is PBM undervalued or overvalued?
Technical Analysis of PBM?
What is the analyst consensus for PBM?